# Bright Minds Biosciences Inc. (DRUG)

Source: https://www.quantisnow.com/company/DRUG
Generated: 2026-11-07T01:09:37.576Z

- Ticker: DRUG
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- SEC CIK: 0001827401
- Website: brightmindsbio.com

## About

Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.

## Latest DRUG news and filings

- 2026-11-04 15:10 UTC [Market Insight] [DRUG Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Bright Minds Biosciences (DRUG)](https://www.quantisnow.com/insight/drug-investor-alert-levi-korsinsky-notifies-investors-of-investigation-into-6771796)
- 2026-11-02 21:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bright-minds-biosciences-inc-6767476)
- 2026-11-02 12:30 UTC [Bright Minds Biosciences Provides Update About Planned Study with BMB-101 in Developmental and Epileptic Encephalopathies](https://www.quantisnow.com/insight/bright-minds-biosciences-provides-update-about-planned-study-with-bmb-101-6766096)
- 2026-10-15 12:45 UTC [Analyst Coverage Initiated] [Wolfe Research initiated coverage on Bright Minds Biosciences with a new price target](https://www.quantisnow.com/insight/wolfe-research-initiated-coverage-on-bright-minds-biosciences-with-a-6747475)
- 2026-10-02 21:14 UTC [SEC Form 6-K] [SEC Form 6-K filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bright-minds-biosciences-inc-6735239)
- 2026-09-30 22:25 UTC [SEC Form 6-K] [SEC Form 6-K filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bright-minds-biosciences-inc-6731186)
- 2026-09-30 21:30 UTC [Conference Announcement] [Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference](https://www.quantisnow.com/insight/bright-minds-biosciences-to-participate-in-the-2026-fpwr-research-6731005)
- 2026-09-04 20:30 UTC [Conference Announcement] [Bright Minds Biosciences to Present at Upcoming Conferences](https://www.quantisnow.com/insight/bright-minds-biosciences-to-present-at-upcoming-conferences-6706841)
- 2026-08-14 18:02 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-bright-minds-biosciences-6682662)
- 2026-08-13 00:47 UTC [SEC Form S-8] [SEC Form S-8 filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-bright-minds-biosciences-inc-6678977)
- 2026-08-12 16:05 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-bright-minds-biosciences-6677433)
- 2026-07-31 12:30 UTC [Leadership Update] [Vistagen Appoints Douglas J. Williamson to its Board of Directors](https://www.quantisnow.com/insight/vistagen-appoints-douglas-j-williamson-to-its-board-of-directors-6657261)
- 2026-06-03 10:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bright-minds-biosciences-inc-6585650)
- 2026-06-02 15:38 UTC [SEC Form 6-K] [SEC Form 6-K filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bright-minds-biosciences-inc-6583724)
- 2026-05-28 00:03 UTC [SEC Form 6-K] [SEC Form 6-K filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bright-minds-biosciences-inc-6575889)
- 2026-05-26 23:18 UTC [Conference Announcement] [Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference](https://www.quantisnow.com/insight/bright-minds-biosciences-to-present-at-jefferies-global-healthcare-conference-6573388)
- 2026-05-15 16:36 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-bright-minds-biosciences-6556577)
- 2026-05-15 16:36 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-bright-minds-biosciences-6556574)
- 2026-04-30 20:08 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-bright-minds-biosciences-6524344)
- 2026-04-30 20:07 UTC [SEC Form 4] [Former 10% Owner Cormorant Asset Management, Lp sold $9,785,124 worth of shares (109,331 units at $89.50) (SEC Form 4)](https://www.quantisnow.com/insight/former-10-owner-cormorant-asset-management-lp-sold-9785124-worth-6524325)
- 2026-04-13 12:51 UTC [Analyst Coverage Initiated] [Jefferies initiated coverage on Bright Minds Biosciences with a new price target](https://www.quantisnow.com/insight/jefferies-initiated-coverage-on-bright-minds-biosciences-with-a-new-6497400)
- 2026-02-25 21:30 UTC [Conference Announcement] [Bright Minds Biosciences to Present at Upcoming Conferences](https://www.quantisnow.com/insight/bright-minds-biosciences-to-present-at-upcoming-conferences-6413369)
- 2026-02-17 21:33 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-bright-minds-biosciences-6396585)
- 2026-02-17 21:00 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-bright-minds-biosciences-6395674)
- 2026-02-13 11:04 UTC [SEC Form 6-K] [SEC Form 6-K filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bright-minds-biosciences-inc-6390950)
- 2026-02-06 20:00 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-bright-minds-biosciences-6379547)
- 2026-01-09 21:11 UTC [SEC Form 6-K] [SEC Form 6-K filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bright-minds-biosciences-inc-6344403)
- 2026-01-09 16:56 UTC [Public Offering] [Bright Minds Biosciences Announces Closing of US$175 Million Public Offering](https://www.quantisnow.com/insight/bright-minds-biosciences-announces-closing-of-us175-million-public-offering-6344150)
- 2026-01-09 00:32 UTC [SEC Form 6-K] [SEC Form 6-K filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bright-minds-biosciences-inc-6343711)
- 2026-01-09 00:02 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-bright-minds-biosciences-inc-6343708)
- 2026-01-08 02:37 UTC [SEC Form 6-K] [SEC Form 6-K filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bright-minds-biosciences-inc-6341983)
- 2026-01-08 02:33 UTC [Public Offering] [Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock](https://www.quantisnow.com/insight/bright-minds-biosciences-announces-pricing-of-upsized-us175-million-public-6341901)
- 2026-01-07 22:27 UTC [SEC Form 6-K] [SEC Form 6-K filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bright-minds-biosciences-inc-6341635)
- 2026-01-07 20:16 UTC [SEC Form FWP] [SEC Form FWP filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-fwp-filed-by-bright-minds-biosciences-inc-6340914)
- 2026-01-07 02:55 UTC [SEC Form FWP] [SEC Form FWP filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-fwp-filed-by-bright-minds-biosciences-inc-6340069)
- 2026-01-07 02:54 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-bright-minds-biosciences-inc-6340063)
- 2026-01-06 22:27 UTC [SEC Form 6-K] [SEC Form 6-K filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bright-minds-biosciences-inc-6339318)
- 2026-01-06 21:00 UTC [Public Offering] [Bright Minds Biosciences Announces Launch of US$100 Million Public Offering](https://www.quantisnow.com/insight/bright-minds-biosciences-announces-launch-of-us100-million-public-offering-6338143)
- 2026-01-06 12:16 UTC [Earnings Date] [Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)](https://www.quantisnow.com/insight/bright-minds-biosciences-announces-positive-topline-results-from-phase-2-6337165)
- 2026-01-05 22:25 UTC [SEC Form 6-K] [SEC Form 6-K filed by Bright Minds Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bright-minds-biosciences-inc-6335972)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/DRUG
- Earnings history: https://www.quantisnow.com/earnings/DRUG
- Dividend history: https://www.quantisnow.com/dividends/DRUG
- Insider transactions: https://www.quantisnow.com/insiders/DRUG
- Options chain: https://www.quantisnow.com/options/DRUG
- SEC 8-K filings only: https://www.quantisnow.com/company/DRUG/8-k
- RSS and alerts for DRUG: https://www.quantisnow.com/docs/rss-feeds.md